MedTrace Logo

HeRO Vascular Access Device Bacteremia Study

NCT00889564 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 38

Last updated 2017-08-08

No results posted yet for this study

Summary

The purpose of this study is to compare the safety and effectiveness of the HeRO Vascular Access Device in access challenged (e.g., catheter-dependent) hemodialysis patients. It is hypothesized the bacteremia rate associated with the HeRO device will be lower than a historical literature control of tunneled dialysis catheters.

Conditions

  • Hemodialysis

Interventions

DEVICE

HeRO Vascular Access Device

Long-term subcutaneous vascular access device for hemodialysis

Sponsors & Collaborators

  • Integra Clinical Trial Solutions - statistical analysis

    collaborator UNKNOWN

  • Ross, John, M.D.

    collaborator INDIV

  • Merit Medical Systems, Inc.

    lead INDUSTRY

Principal Investigators

  • John Ross, MD · Bamberg County Hospital

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-03-31
Primary Completion
2007-03-31
Completion
2007-03-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00889564 on ClinicalTrials.gov